Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Berg

Showing results (461-470 of 493) with videos related to

Pageof 50
Sort By:
Journal of Parkinson'S Disease|March 8, 2021
Parkinson's Disease Subtypes: Critical Appraisal and RecommendationsTiago A Mestre, Seyed-Mohammad Fereshtehnejad, Daniela Berg, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Journal of Parkinson'S Disease|February 20, 2025
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studiesDavid Devos, Olivier Rascol, Wassilios G Meissner, et al.
Parkinsonism & Related Disorders|January 15, 2015
TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter studySara Ortega-Cubero, Oswaldo Lorenzo-Betancor, Elena Lorenzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2019
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility SystemThilo van Eimeren, Angelo Antonini, Daniela Berg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Journal of Neurology|June 4, 2020
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complicationsAristide Merola, Alberto Romagnolo, Alok K Dwivedi, et al.
Pageof 50

Showing results (461-470 of 493) with videos related to

Sort By:
Pageof 50
Journal of Parkinson'S Disease|March 8, 2021
Parkinson's Disease Subtypes: Critical Appraisal and RecommendationsTiago A Mestre, Seyed-Mohammad Fereshtehnejad, Daniela Berg, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 20, 2021
Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessmentsAnja Ophey, Steffen Wolfsgruber, Sandra Roeske, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Journal of Parkinson'S Disease|February 20, 2025
Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studiesDavid Devos, Olivier Rascol, Wassilios G Meissner, et al.
Parkinsonism & Related Disorders|January 15, 2015
TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter studySara Ortega-Cubero, Oswaldo Lorenzo-Betancor, Elena Lorenzo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 10, 2018
Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Ines Ann Heber, Petra Neuser, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 16, 2019
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility SystemThilo van Eimeren, Angelo Antonini, Daniela Berg, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 26, 2024
A Short Progressive Supranuclear Palsy Quality of Life ScaleIda Wilkens, Stephanie Stiel, Sarah Bebermeier, et al.
Journal of Neurology|June 4, 2020
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complicationsAristide Merola, Alberto Romagnolo, Alok K Dwivedi, et al.
Pageof 50